Bind nanomedicine assets may go to Pfizer | Chemical & Engineering News
Volume 94 Issue 28 | p. 15 | Concentrates
Issue Date: July 11, 2016

Bind nanomedicine assets may go to Pfizer

Department: Business
Keywords: mergers & acquisitions, nanomedicine, bankruptcy

Bind Therapeutics, which filed for bankruptcy in May, has signed a preliminary agreement to sell most of its assets to Pfizer for close to $20 million. If the company receives a higher bid by July 22, it will auction its assets. If Pfizer’s offer is selected as the highest, or no better bids come in, Bind expects to complete the sale, subject to court approval, in the third quarter. Bind and Pfizer became collaborators through a multi-million-dollar deal in April 2013.

 
Chemical & Engineering News
ISSN 0009-2347
Copyright © American Chemical Society

Leave A Comment

*Required to comment